ETHIXDOXY-LB

10x10 capsules

ETHIXDOXY-LB is a combination antibiotic containing Doxycycline and Lactic Acid Bacillus. Doxycycline is a broad-spectrum tetracycline-class antibiotic used to treat bacterial infections, while Lactic Acid Bacillus helps restore gut flora and prevents antibiotic-associated diarrhea. This combination is effective in treating respiratory infections, skin infections, sexually transmitted diseases (STDs), urinary tract infections (UTIs), and gastrointestinal infections.

While generally well-tolerated, ETHIXDOXY-LB may cause:

• Common Side Effects: Nausea, vomiting, diarrhea, stomach pain, and headache.
• Serious Side Effects: Severe allergic reactions (rash, swelling, difficulty breathing), liver toxicity, photosensitivity (increased sensitivity to sunlight), and esophageal irritation.
• Long-Term Effects: Prolonged use may lead to antibiotic resistance, fungal infections, or vitamin deficiencies.

• Take ETHIXDOXY-LB exactly as prescribed by your doctor.
• Swallow the capsule whole with a full glass of water.
• Do not lie down immediately after taking the capsule to avoid esophageal irritation.
• Best taken on an empty stomach, at least 1 hour before or 2 hours after meals. If stomach upset occurs, take it with food or milk.
• Complete the full course of treatment even if symptoms improve early.

• Take ETHIXDOXY-LB exactly as prescribed by your doctor.
• Swallow the capsule whole with a full glass of water.
• Do not lie down immediately after taking the capsule to avoid esophageal irritation.
• Best taken on an empty stomach, at least 1 hour before or 2 hours after meals. If stomach upset occurs, take it with food or milk.
• Complete the full course of treatment even if symptoms improve early.

Do not take ETHIXDOXY-LB if you:

• Are allergic to Doxycycline, Tetracyclines, or Lactic Acid Bacillus.
• Have severe liver disease.
• Are pregnant or breastfeeding.
• Have esophageal disorders (risk of irritation and ulcers).
• Are under 8 years of age (may cause permanent teeth discoloration).

Do not take ETHIXDOXY-LB if you:

• Are allergic to Doxycycline, Tetracyclines, or Lactic Acid Bacillus.
• Have severe liver disease.
• Are pregnant or breastfeeding.
• Have esophageal disorders (risk of irritation and ulcers).
• Are under 8 years of age (may cause permanent teeth discoloration).

Recommended Dosage for Adults

• Mild Infections: 100 mg once daily or 50 mg twice daily.
• Severe Infections: 100 mg twice daily.
• Acne Treatment: 50-100 mg daily for 6-12 weeks.
• Malaria Prophylaxis: 100 mg once daily, starting 1-2 days before travel and continued for 4 weeks after leaving the endemic area.

Children (Above 8 Years, Weight-Based)

• 2 mg/kg body weight every 12 hours (not exceeding adult dose).

Missed Dose: Take the missed dose as soon as possible unless it's close to the next dose. Do not double dose.

Overdose: Seek immediate medical attention if overdose symptoms (vomiting, liver toxicity) occur.

Drug Interactions

• Antacids & Dairy Products: Reduce doxycycline absorption. Take ETHIXDOXY-LB 2 hours before or after such products.
• Blood Thinners (Warfarin): Increases risk of bleeding.
• Oral Contraceptives: May reduce birth control effectiveness; use backup contraception.
• Anti-Seizure Medications (Phenytoin, Carbamazepine): Decrease doxycycline levels.
• Iron & Zinc Supplements: May reduce absorption; take separately.

• Take with plenty of water to prevent esophageal irritation.
• Avoid alcohol as it may worsen side effects.
• Do not take expired Doxycycline, as it may cause kidney damage.
• Monitor for allergic reactions, especially if taking for the first time.
• If taking for acne, results may take 6-12 weeks.

• Storage: Store below 25°C in a dry, cool place, away from direct sunlight.
• Formulation: Hard gelatin capsule containing Doxycycline (100 mg) + Lactic Acid Bacillus.
• Shelf Life: Typically 24-36 months.
• Availability: Prescription-only medication.

• National Center for Biotechnology Information (NCBI) – Doxycycline Pharmacology
• World Health Organization (WHO) – Guidelines for Antibiotic Use
• Indian Pharmacopoeia (IP) – Standard Drug Formulation
• U.S. Food and Drug Administration (FDA) – Drug Safety Alerts